Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin
Author(s) -
Hiroshi Ishimoto,
Hiroshi Mukae,
Noriho Sakamoto,
Misato Amenomori,
Takeshi Kitazaki,
Yoshifumi Imamura,
Hanako Fujita,
Hiroshi Ishii,
Seiko Nakayama,
K. Yanagihara,
Shigekatsu Kohno
Publication year - 2008
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkn427
Subject(s) - diffuse panbronchiolitis , clarithromycin , azithromycin , antibiotics , cystic fibrosis , macrolide antibiotics , mucin , telithromycin , medicine , erythromycin , microbiology and biotechnology , lipopolysaccharide , antimicrobial , peptide , immunology , pharmacology , biology , pathology , biochemistry
Mucus hypersecretion is a prominent feature in patients with chronic respiratory tract infections such as cystic fibrosis and diffuse panbronchiolitis, and the clinical effectiveness of macrolide antibiotics has been reported in these patients. Because human neutrophil peptide-1 (HNP-1), an antimicrobial peptide in neutrophils, exists in high concentrations in the airway fluid of these patients, we examined the direct effect of HNP-1 on MUC5AC mucin production using NCI-H292 cells. The effects of macrolide antibiotics on the response were also examined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom